For the Inventor, By the Inventor

Enter inventor name

Chicago, IL, United States of America

Aly Azeem Khan

USPTO Granted Patents = 19 (Patent Applications = 18)

EPO Patents = 2 (Patent Applications = 12)

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 56(Granted Patents)

Company Filing History:

Tempus Labs, Inc.

Tempus Ai, Inc.

Years Active: 2021-2025

where 'Filed Patents' based on already Granted Patents

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12451250 - Systems and methods for predicting therapeutic sensitivity (2025-10-21),

2. 12165236 - Predicting total nucleic acid yield and dissection boundaries for histology slides (2024-12-10),

3. 12129519 - TCR/BCR profiling using enrichment with pools of capture probes (2024-10-29),

4. 12112839 - Data based cancer research and treatment systems and methods (2024-10-08),

5. 11935152 - Determining biomarkers from histopathology slide images (2024-03-19),

6. 11741365 - Generalizable and interpretable deep learning framework for predicting MSI from histopathology slide images (2023-08-29),

7. 11727674 - Systems and methods for generating histology image training datasets for machine learning models (2023-08-15),

8. 11705226 - Data based cancer research and treatment systems and methods (2023-07-18),

9. 11640859 - Data based cancer research and treatment systems and methods (2023-05-02),

10. 11610307 - Determining biomarkers from histopathology slide images (2023-03-21),

11. 11561178 - Artificial fluorescent image systems and methods (2023-01-24),

12. 11415571 - Large scale organoid analysis (2022-08-16),

13. 11414700 - TCR/BCR profiling using enrichment with pools of capture probes (2022-08-16),

14. 11348661 - Predicting total nucleic acid yield and dissection boundaries for histology slides (2022-05-31),

15. 11348240 - Predicting total nucleic acid yield and dissection boundaries for histology slides (2022-05-31),

Title: Innovations and Contributions of Inventor Aly Azeem Khan

Introduction: Aly Azeem Khan is an accomplished inventor based in Chicago, IL. With a remarkable portfolio of 18 patents, Khan has made significant contributions to the fields of biotechnology and medical diagnostics. His innovative methods and systems have the potential to transform practices in healthcare and research.

Latest Patents: Among his most recent patents, one focuses on a method for predicting total nucleic acid yield and dissection boundaries for histology slides. This invention allows for a better assessment of tumor cell nucleic acids by qualifying specimens prepared on one or more hematoxylin and eosin (H&E) slides. Another noteworthy patent involves T cell receptor (TCR) and B cell receptor (BCR) profiling. This method utilizes next-generation sequencing (NGS) techniques to create systems for diagnosing and predicting medical conditions based on TCR/BCR profile data.

Career Highlights: Aly Azeem Khan has been involved with notable companies such as Tempus Labs, Inc. and Tempus AI, Inc. Through these roles, he has contributed to advancements in data-driven medical solutions that enhance patient care and treatment strategies.

Collaborations: Throughout his career, Khan has collaborated with skilled professionals, including notable coworkers Stephen Yip and Irvin Ho. Together, they have worked towards achieving innovation in their respective fields, further elevating the impact of their contributions to medical science.

Conclusion: Aly Azeem Khan stands out as a passionate inventor whose work reflects a commitment to advancing healthcare through innovation. His patents and industry collaborations highlight his significant role in developing technologies that have the potential to improve diagnostic and therapeutic methodologies. As he continues to innovate, Khan's influence in biotechnology will likely lead to further advancement in the medical field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…